SINGLE AND MULTIPLE DOSE PHARMACOKINETICS OF PINDOLOL

被引:29
作者
GUGLER, R [1 ]
BODEM, G [1 ]
机构
[1] UNIV BONN,DEPT MED,D-5300 BONN 1,FED REP GER
关键词
D O I
10.1007/BF00606675
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:13 / 16
页数:4
相关论文
共 17 条
[1]   COMBINED PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES ON ALPRENOLOL AND 4-HYDROXY-ALPRENOLOL IN MAN [J].
ABLAD, B ;
BORG, KO ;
JOHNSSON, G ;
REGARDH, CG ;
SOLVELL, L .
LIFE SCIENCES, 1974, 14 (04) :693-704
[2]   BETA-ADRENOCEPTOR BLOCKING ACTIVITY AND DURATION OF ACTION OF PINDOLOL AND PROPRANOLOL IN HEALTHY VOLUNTEERS [J].
AELLIG, WH .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (02) :251-257
[3]  
BODEM G, 1973, CLIN PHARMACOL THER, V14, P26
[4]  
BRANCH R A, 1976, Clinical Pharmacokinetics, V1, P264
[5]  
EVANS GH, 1973, CLIN PHARMACOL THER, V14, P487
[6]   EFFECT OF PINDOLOL ON EXERCISE-INDUCED CARDIAC ACCELERATION IN RELATION TO PLASMA-LEVELS IN MAN [J].
GUGLER, R ;
HOBEL, W ;
BODEM, G ;
DENGLER, HJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1975, 17 (02) :127-133
[7]   PHARMACOKINETICS OF PINDOLOL IN MAN [J].
GUGLER, R ;
HEROLD, W ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (01) :17-24
[8]  
JOHNSSON G, 1976, Clinical Pharmacokinetics, V1, P233
[9]  
JOHNSSON G, 1975, ACTA PHARMACOL TOX, V36, P31
[10]  
NIES A S, 1976, Clinical Pharmacokinetics, V1, P135, DOI 10.2165/00003088-197601020-00005